INTEGRAL HEALTH ASSET MANAGEMENT LLC
Q1 2026 Form 13-F
NEW YORK, NEW YORK
CIK 0001773206
· CRD 301987
· SEC-registered investment adviser
$2.1B Reported Value Total
INTEGRAL HEALTH ASSET MANAGEMENT, LLC reports 13 total accounts under management (AUM). There are 13 discretionary accounts valued at $1,872,690,688, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
1 fund
· $60.2M gross asset value
Hedge Fund: $60.2M
Source: Form ADV filed 2026-03-26
Reported value
$2.1B
Quarter over quarter
-3.0%
Holdings
86
Top-10 concentration
44.5%
Key People
Form ADV owners & control persons
Bhagwan Jay Rao
MANAGING MEMBER
John Del Virginia
CHIEF COMPLIANCE OFFICER & CHIEF OPERATING OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2026 13F record
Q1 2026 13F filing summary
| Period of report | March 31, 2026 |
|---|---|
| Filed | May 15, 2026 |
| Form | 13F-HR |
| Reported value | $2.1B |
| Positions | 86 |
| Change in reported value | +3.8% |
| New positions | 28 |
| Exited positions | 26 |
| Position turnover | 48.2% |
| Top-10 concentration | 44.5% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
89 | $2.5B |
|
Q1 2026 13F
Filed May 15, 2026
|
86 | $2.1B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
84 | $2.0B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
72 | $1.5B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
70 | $1.1B |
|
Q1 2025 13F
Filed May 15, 2025
|
76 | $939.8M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
81 | $1.2B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
63 | $888.7M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
69 | $1.1B |
|
Q1 2024 13F
Filed May 15, 2024
|
76 | $1.1B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
67 | $734.3M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
62 | $722.3M |
|
Q2 2023 13F
Filed Aug 11, 2023
|
70 | $807.6M |
|
Q1 2023 13F
Filed May 9, 2023
|
67 | $496.4M |
|
Q4 2022 13F
Filed Feb 13, 2023
|
59 | $476.4M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
64 | $514.8M |
|
Q2 2022 13F
Filed Aug 3, 2022
|
65 | $486.2M |
|
Q1 2022 13F
Filed May 12, 2022
|
71 | $384.3M |
|
Q4 2021 13F
Filed Feb 2, 2022
|
70 | $361.4M |
|
Q3 2021 13F
Filed Nov 12, 2021
|
70 | $347.9M |
7 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q1 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | INSM INSMED INC | $245.3M | 11.73% |
| 2 | RVMD REVOLUTION MEDICINES INC | $145.9M | 6.98% |
| 3 | CYTK CYTOKINETICS INC | $105.5M | 5.04% |
| 4 | RVMD P REVOLUTION MEDICINES INC | $72.9M | 3.49% |
| 5 | CYTK C CYTOKINETICS INC | $65.9M | 3.15% |
| 6 | REGN REGENERON PHARMACEUTICALS | $65.7M | 3.14% |
| 7 | VERA VERA THERAPEUTICS INC | $64.4M | 3.08% |
| 8 | CAH CARDINAL HEALTH INC | $57.1M | 2.73% |
| 9 | ROIV ROIVANT SCIENCES LTD | $55.4M | 2.65% |
| 10 | BTSG BRIGHTSPRING HEALTH SVCS INC | $53.3M | 2.55% |
| 11 | RYTM RHYTHM PHARMACEUTICALS INC | $52.2M | 2.5% |
| 12 | MRK MERCK & CO INC | $51.1M | 2.45% |
| 13 | EWTX EDGEWISE THERAPEUTICS INC | $50.4M | 2.41% |
| 14 | AZN ASTRAZENECA PLC | $49.3M | 2.36% |
| 15 | RVMD C REVOLUTION MEDICINES INC | $48.6M | 2.33% |
| 16 | ALHC ALIGNMENT HEALTHCARE INC | $45.4M | 2.17% |
| 17 | NVS NOVARTIS AG | $38.2M | 1.83% |
| 18 | BSX BOSTON SCIENTIFIC CORP | $34.5M | 1.65% |
| 19 | LFST LIFESTANCE HEALTH GROUP INC | $27.4M | 1.31% |
| 20 | ASND ASCENDIS PHARMA A/S | $26.3M | 1.26% |
Values as reported on the Q1 2026 Form 13F. Every position is in the holdings table below.